Low-dose glimepiride with sitagliptin improves glycemic control without dose-dependency in patients with type 2 diabetes inadequately controlled on high-dose glimepiride - Umayahara, R; Yonemoto, T; Kyou, C (Endocr J, 2014)
et al.